CISPLATIN AND CONTINUOUS-INFUSION OF FLUOROURACIL FOLLOWED BY RADIATION AND WEEKLY CARBOPLATIN IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
G. Fountzilas et al., CISPLATIN AND CONTINUOUS-INFUSION OF FLUOROURACIL FOLLOWED BY RADIATION AND WEEKLY CARBOPLATIN IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Cancer investigation, 14(3), 1996, pp. 189-196
Induction chemotherapy followed by radiation has been extensively stud
ied in an effort to improve local control and possibly overall surviva
l of patients with locally advanced head and neck cancer. From June 19
89 until May 1991, 39 patients with locally advanced squamous cell car
cinoma of the head and neck (SCCHN) were treated with 3 cycles of indu
ction chemotherapy, consisting of cisplatin (100 mg/m(2) d 1) and fluo
rouracil (1000 mg/m(2) d 2-6) followed by radiation potentiated by wee
kly administration of carboplatin (60 mg/m(2)). Surgery was performed
in selected patients with residual disease after the combined modality
approach. Four cycles of adjuvant chemotherapy with carboplatin (325
mg/m(2)) and bleomycin (15 u) were administered in those patients who
demonstrated a partial response after locoregional treatment. There we
re 36 men and 3 women with a median age of 56 (range 39-74) years and
Karnofsky performance status of 70 (range 60-100). The primary site of
the tumor was nasopharynx (8), oropharynx (8), hypopharynx (3), oral
cavity (4), larynx (13), paranasal sinus (2), and salivary glands (1).
Thirty-two (82%) patients presented with stage IV disease. After the
completion of induction chemotherapy, 14 (36%, 95% CI 21-53%) patients
achieved a complete response (CR). This CR rate was increased to 56%
(95% CI, 42-74%) after locoregional treatment. Main toxicities include
d nausea/vomiting (56%), leukopenia (40%), anemia (30%), thrombocytope
nia (10%), stomatitis (28%), diarrhea (17%), and alopecia (12%). Media
n relapse-free survival was 18 (1-50) months, median time to progressi
on was 13 (0.3-58.5) months, and median survival 19 (0.3-59) months. I
nduction chemotherapy with cisplatin and fluorouracil followed by radi
ation potentiated with carboplatin is feasible. However, this combined
modality approach, as applied in the present study, does not appear t
o yield superior results than those reported with chemotherapy followe
d by radiation alone.